Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979495 · ClinicalTrials.gov registry record · NA
mFOCUS (Multilevel FOllow-up of Cancer Screening)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11,980
- Enrollment target
NCT03979495: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03979495 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 11,980 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (754% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03979495, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,980 participants
- Enrollment target
Study Summary
To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal cancer screening test.
Primary Outcome
Completion of follow-up test within 120 days of eligibility for mFOCUS (EHR)
Interventions
- OTHER mFOCUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,980 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
What the finished NCT03979495 record still lists
NCT03979495 is an interventional study that assigns participants to a tested intervention. Its 11,980 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (754% higher).
The record links to 0 conditions, and to 1 intervention - of which mFOCUS is the first listed.
NCT03979495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03979495 about?
NCT03979495 is a clinical study titled "mFOCUS (Multilevel FOllow-up of Cancer Screening)". To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal cancer screening test.
What is the current status of trial NCT03979495?
This trial is currently completed. It is a NA study. The enrollment target is 11,980 participants. The study started on 2020-08-24. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT03979495?
The interventions under investigation include: mFOCUS (OTHER).
Who is sponsoring clinical trial NCT03979495?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03979495's enrollment target sits among peer trials
11,980 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI